Sensodyne Whitening Claims Receive Dim Review From UK Regulator
This article was originally published in The Rose Sheet
Executive Summary
Advertising Standards Authority reviewed claims GSK's GlaxoSmithKline Consumer Healthcare Trading Ltd. made online for Sensodyne True White after a Colgate-Palmolive Co. subsidiary argued that the toothpaste’s whitening effect was no greater than standard non-whitening toothpastes and challenged whether the claims that it was effective at whitening teeth were misleading.
You may also be interested in...
Colgate's UK Whitening Claims Shine On Clinical Data, Consumer Perception
Colgate substantiates claims in TV and online ads for Colgate Max White Expert White toothpaste and Max White toothbrush with clinical and consumer perception studies showing the products could make teeth “3 shades whiter” in five days.
Colgate Max White 'Instant' Benefit Claims Not Exaggerated Overall – ASA
A Colgate-Palmolive clinical study for Max White One Optic toothpaste adequately supports its "instantly whiter" advertising in the UK, but results were not so pronounced as to justify a "much whiter" claim, according to the Advertising Standards Authority. Procter & Gamble UK was the challenger in the case.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”